{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T01:19:35Z","timestamp":1789867175722,"version":"4.0.1"},"reference-count":130,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.jaut.2016.08.005","type":"journal-article","created":{"date-parts":[[2016,8,22]],"date-time":"2016-08-22T07:50:01Z","timestamp":1471852201000},"page":"20-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Current trends in autoimmunity and the nervous system"],"prefix":"10.1016","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0323-0376","authenticated-orcid":false,"given":"Carlo","family":"Selmi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jobert G.","family":"Barin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noel R.","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2016.08.005_bib1","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3389\/fimmu.2015.00206","article-title":"Neuroimmunology: an expanding frontier in autoimmunity","volume":"6","author":"Hoftberger","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2016.08.005_bib2","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuron.2008.01.003","article-title":"The blood-brain barrier in health and chronic neurodegenerative disorders","volume":"57","author":"Zlokovic","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.jaut.2016.08.005_bib3","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12987-015-0017-7","article-title":"Adenosine receptor signaling: a key to opening the blood-brain door","volume":"12","author":"Bynoe","year":"2015","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.jaut.2016.08.005_bib4","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1038\/nm.3407","article-title":"Development, maintenance and disruption of the blood-brain barrier","volume":"19","author":"Obermeier","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.jaut.2016.08.005_bib5","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/cne.903610410","article-title":"Type 1 interleukin-1 receptor in the rat brain: distribution, regulation, and relationship to sites of IL-1-induced cellular activation","volume":"361","author":"Ericsson","year":"1995","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.jaut.2016.08.005_bib6","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1046\/j.1471-4159.1997.69041668.x","article-title":"Regulation of the genes encoding interleukin-6, its receptor, and gp130 in the rat brain in response to the immune activator lipopolysaccharide and the proinflammatory cytokine interleukin-1beta","volume":"69","author":"Vallieres","year":"1997","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.jaut.2016.08.005_bib7","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/S0306-4522(99)00225-0","article-title":"Effects of circulating tumor necrosis factor on the neuronal activity and expression of the genes encoding the tumor necrosis factor receptors (p55 and p75) in the rat brain: a view from the blood-brain barrier","volume":"93","author":"Nadeau","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.jaut.2016.08.005_bib8","article-title":"The blood-brain barrier in systemic inflammation","author":"Varatharaj","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jaut.2016.08.005_bib9","doi-asserted-by":"crossref","first-page":"9325","DOI":"10.1073\/pnas.0711175105","article-title":"CD73 is required for efficient entry of lymphocytes into the central nervous system during experimental autoimmune encephalomyelitis","volume":"105","author":"Mills","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jaut.2016.08.005_bib10","doi-asserted-by":"crossref","first-page":"13272","DOI":"10.1523\/JNEUROSCI.3337-11.2011","article-title":"Adenosine receptor signaling modulates permeability of the blood-brain barrier","volume":"31","author":"Carman","year":"2011","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.jaut.2016.08.005_bib11","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1242\/jcs.114.7.1343","article-title":"Rho and Rac but not Cdc42 regulate endothelial cell permeability","volume":"114","author":"Wojciak-Stothard","year":"2001","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.jaut.2016.08.005_bib12","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jviromet.2004.06.013","article-title":"In\u00a0vitro assessment of human endothelial cell permeability: effects of inflammatory cytokines and dengue virus infection","volume":"121","author":"Dewi","year":"2004","journal-title":"J.\u00a0Virol. Methods"},{"key":"10.1016\/j.jaut.2016.08.005_bib13","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s11302-005-5302-5","article-title":"Physiological roles for ecto-5'-nucleotidase (CD73)","volume":"2","author":"Colgan","year":"2006","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.jaut.2016.08.005_bib14","doi-asserted-by":"crossref","first-page":"5262","DOI":"10.4049\/jimmunol.165.9.5262","article-title":"Regulation of endothelial CD73 by adenosine: paracrine pathway for enhanced endothelial barrier function","volume":"165","author":"Narravula","year":"2000","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2016.08.005_bib15","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1161\/01.RES.0000144796.82787.6f","article-title":"Targeted disruption of cd73\/ecto-5'-nucleotidase alters thromboregulation and augments vascular inflammatory response","volume":"95","author":"Koszalka","year":"2004","journal-title":"Circ. Res."},{"key":"10.1016\/j.jaut.2016.08.005_bib16","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1126\/science.1137190","article-title":"Cell biology. Purinergic chemotaxis","volume":"314","author":"Linden","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.jaut.2016.08.005_bib17","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/nri1705","article-title":"Cell-surface enzymes in control of leukocyte trafficking","volume":"5","author":"Salmi","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jaut.2016.08.005_bib18","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.4049\/jimmunol.1003671","article-title":"Tissue-resident ecto-5' nucleotidase (CD73) regulates leukocyte trafficking in the ischemic brain","volume":"188","author":"Petrovic-Djergovic","year":"2012","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2016.08.005_bib19","doi-asserted-by":"crossref","first-page":"6288","DOI":"10.4049\/jimmunol.180.9.6288","article-title":"CD73-generated adenosine restricts lymphocyte migration into draining lymph nodes","volume":"180","author":"Takedachi","year":"2008","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2016.08.005_bib20","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/nm1177","article-title":"Experimental autoimmune encephalomyelitis repressed by microglial paralysis","volume":"11","author":"Heppner","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.jaut.2016.08.005_bib21","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nm1197","article-title":"Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis","volume":"11","author":"Greter","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.jaut.2016.08.005_bib22","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/ncpneuro0154","article-title":"Immunopathogenesis and immunotherapy of multiple sclerosis","volume":"2","author":"Hemmer","year":"2006","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"10.1016\/j.jaut.2016.08.005_bib23","doi-asserted-by":"crossref","first-page":"4497","DOI":"10.4049\/jimmunol.170.9.4497","article-title":"Determinants of human B cell migration across brain endothelial cells","volume":"170","author":"Alter","year":"2003","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2016.08.005_bib24","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1750-3639.1992.tb00703.x","article-title":"Drainage of brain extracellular fluid into blood and deep cervical lymph and its immunological significance","volume":"2","author":"Cserr","year":"1992","journal-title":"Brain Pathol."},{"key":"10.1016\/j.jaut.2016.08.005_bib25","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1365-2990.1993.tb00476.x","article-title":"CSF drains directly from the subarachnoid space into nasal lymphatics in the rat. Anatomy, histology and immunological significance","volume":"19","author":"Kida","year":"1993","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.jaut.2016.08.005_bib26","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature14432","article-title":"Structural and functional features of central nervous system lymphatic vessels","volume":"523","author":"Louveau","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2016.08.005_bib27","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1084\/jem.20142290","article-title":"A\u00a0dural lymphatic vascular system that drains brain interstitial fluid and macromolecules","volume":"212","author":"Aspelund","year":"2015","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.jaut.2016.08.005_bib28","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.it.2015.08.006","article-title":"Revisiting the mechanisms of CNS immune privilege","volume":"36","author":"Louveau","year":"2015","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jaut.2016.08.005_bib29","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jaut.2014.01.021","article-title":"The classification and diagnosis of cutaneous lupus erythematosus","volume":"48\u201349","author":"Kuhn","year":"2014","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jaut.2016.08.005_bib30","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jaut.2014.01.004","article-title":"Diagnostic criteria for systemic lupus erythematosus: a critical review","volume":"48\u201349","author":"Yu","year":"2014","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jaut.2016.08.005_bib31","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1212\/WNL.57.3.496","article-title":"The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus","volume":"57","author":"Ainiala","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2016.08.005_bib32","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nrrheum.2010.62","article-title":"Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations","volume":"6","author":"Bertsias","year":"2010","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jaut.2016.08.005_bib33","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.semarthrit.2012.03.011","article-title":"Neuropsychiatric lupus: the prevalence and autoantibody associations depend on the definition: results from the 1000 faces of lupus cohort","volume":"42","author":"Borowoy","year":"2012","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.08.005_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semarthrit.2010.08.001","article-title":"Neuropsychiatric syndromes in systemic lupus erythematosus: a meta-analysis","volume":"41","author":"Unterman","year":"2011","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.08.005_bib35","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","article-title":"The 1982 revised criteria for the classification of systemic lupus erythematosus","volume":"25","author":"Tan","year":"1982","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.08.005_bib36","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jaut.2015.08.004","article-title":"Immunogenetics of systemic lupus erythematosus: a comprehensive review","volume":"64","author":"Ghodke-Puranik","year":"2015","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jaut.2016.08.005_bib37","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/rheumatology\/ket322","article-title":"Identification of clinical predictors of flare in systemic lupus erythematosus patients: a 24-month prospective cohort study","volume":"53","author":"Ines","year":"2014","journal-title":"Rheumatol. Oxf."},{"key":"10.1016\/j.jaut.2016.08.005_bib38","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1191\/0961203304lu2024oa","article-title":"ACR classification criteria for systemic lupus erythematosus: limitations and revisions to neuropsychiatric variables","volume":"13","author":"Hanly","year":"2004","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2016.08.005_bib39","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1136\/ard.2010.130476","article-title":"EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs","volume":"69","author":"Bertsias","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2016.08.005_bib40","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.rdc.2005.01.007","article-title":"Neuropsychiatric lupus","volume":"31","author":"Hanly","year":"2005","journal-title":"Rheum. Dis. Clin. North Am."},{"key":"10.1016\/j.jaut.2016.08.005_bib41","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrneurol.2014.148","article-title":"Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers","volume":"10","author":"Jeltsch-David","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jaut.2016.08.005_bib42","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jneuroim.2015.08.015","article-title":"TRPC6 gene variants and neuropsychiatric lupus","volume":"288","author":"Ramirez","year":"2015","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.jaut.2016.08.005_bib43","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1136\/ard.2009.114157","article-title":"TREX1 gene variant in neuropsychiatric systemic lupus erythematosus","volume":"69","author":"de Vries","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2016.08.005_bib44","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/gene.2010.73","article-title":"Evaluation of the TREX1 gene in a large multi-ancestral lupus cohort","volume":"12","author":"Namjou","year":"2011","journal-title":"Genes Immun."},{"key":"10.1016\/j.jaut.2016.08.005_bib45","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/art.22419","article-title":"Induction of autoimmune depression in mice by anti-ribosomal P antibodies via the limbic system","volume":"56","author":"Katzav","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.08.005_bib46","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1084\/jem.20071285","article-title":"Antiribosomal-P autoantibodies from psychiatric lupus target a novel neuronal surface protein causing calcium influx and apoptosis","volume":"204","author":"Matus","year":"2007","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.jaut.2016.08.005_bib47","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jaut.2014.01.006","article-title":"Diagnosis and classification of the antiphospholipid syndrome","volume":"48\u201349","author":"Gomez-Puerta","year":"2014","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jaut.2016.08.005_bib48","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jaut.2014.03.001","article-title":"beta2-glycoprotein I, lipopolysaccharide and endothelial TLR4: three players in the two hit theory for anti-phospholipid-mediated thrombosis","volume":"55","author":"Raschi","year":"2014","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jaut.2016.08.005_bib49","doi-asserted-by":"crossref","first-page":"e0119911","DOI":"10.1371\/journal.pone.0119911","article-title":"Intractable headaches, ischemic stroke, and seizures are linked to the presence of anti-beta2GPI antibodies in patients with systemic lupus erythematosus","volume":"10","author":"Hawro","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2016.08.005_bib50","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ana.21050","article-title":"Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma","volume":"61","author":"Dalmau","year":"2007","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jaut.2016.08.005_bib51","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1474-4422(09)70324-2","article-title":"Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen","volume":"9","author":"Lancaster","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jaut.2016.08.005_bib52","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/ana.21589","article-title":"AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location","volume":"65","author":"Lai","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jaut.2016.08.005_bib53","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/nyas.12553","article-title":"Autoimmune encephalopathies","volume":"1338","author":"Leypoldt","year":"2015","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jaut.2016.08.005_bib54","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1474-4422(13)70282-5","article-title":"Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study","volume":"13","author":"Gresa-Arribas","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jaut.2016.08.005_bib55","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jaut.2016.08.005_bib56","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1474-4422(14)70051-1","article-title":"A\u00a0novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study","volume":"13","author":"Sabater","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jaut.2016.08.005_bib57","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1056\/NEJM200009283431307","article-title":"Multiple sclerosis","volume":"343","author":"Noseworthy","year":"2000","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jaut.2016.08.005_bib58","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jaut.2014.01.022","article-title":"The diagnosis of multiple sclerosis and the various related demyelinating syndromes: a critical review","volume":"48\u201349","author":"Karussis","year":"2014","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jaut.2016.08.005_bib59","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jaut.2015.06.010","article-title":"The immunogenetics of multiple sclerosis: a comprehensive review","volume":"64","author":"Hollenbach","year":"2015","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jaut.2016.08.005_bib60","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.autrev.2011.05.006","article-title":"A\u00a0clear look at the neuroimmunology of multiple sclerosis and beyond","volume":"11","author":"Selmi","year":"2012","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2016.08.005_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2014.08.001","article-title":"From defining antigens to new therapies in multiple sclerosis: honoring the contributions of Ruth Arnon and Michael Sela","volume":"54","author":"Steinman","year":"2014","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jaut.2016.08.005_bib62","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jaut.2014.06.004","article-title":"From classic to spontaneous and humanized models of multiple sclerosis: impact on understanding pathogenesis and drug development","volume":"54","author":"Ben-Nun","year":"2014","journal-title":"J.\u00a0Autoimmun."},{"issue":"Pt 8","key":"10.1016\/j.jaut.2016.08.005_bib63","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1093\/brain\/120.8.1461","article-title":"The application of multifactorial cluster analysis in the staging of plaques in early multiple sclerosis. Identification and characterization of the primary demyelinating lesion","volume":"120","author":"Gay","year":"1997","journal-title":"Brain"},{"key":"10.1016\/j.jaut.2016.08.005_bib64","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/ana.410370404","article-title":"The adhesion molecule and cytokine profile of multiple sclerosis lesions","volume":"37","author":"Cannella","year":"1995","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jaut.2016.08.005_bib65","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1056\/NEJM199801293380502","article-title":"Axonal transection in the lesions of multiple sclerosis","volume":"338","author":"Trapp","year":"1998","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jaut.2016.08.005_bib66","article-title":"pDC therapy induces recovery from EAE by recruiting endogenous pDC to sites of CNS inflammation","author":"Duraes","year":"2015","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jaut.2016.08.005_bib67","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1212\/WNL.40.11.1770","article-title":"Myelin basic protein-specific T lymphocyte lines from MS patients and healthy individuals","volume":"40","author":"Pette","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2016.08.005_bib68","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/ana.21939","article-title":"Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?","volume":"67","author":"Bar-Or","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jaut.2016.08.005_bib69","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1084\/jem.20111675","article-title":"B\u00a0cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells","volume":"209","author":"Barr","year":"2012","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.jaut.2016.08.005_bib70","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jneuroim.2015.11.022","article-title":"B\u00a0cells from relapsing remitting multiple sclerosis patients support neuro-antigen-specific Th17 responses","volume":"291","author":"Ireland","year":"2016","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.jaut.2016.08.005_bib71","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00011-016-0936-z","article-title":"The role of adenosine and adenosine receptors in the immunopathogenesis of multiple sclerosis","volume":"65","author":"Safarzadeh","year":"2016","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.jaut.2016.08.005_bib72","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/ana.1007","article-title":"Diminished adenosine A1 receptor expression on macrophages in brain and blood of patients with multiple sclerosis","volume":"49","author":"Johnston","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jaut.2016.08.005_bib73","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/978-3-540-89615-9_17","article-title":"Adenosine receptors and neurological disease: neuroprotection and neurodegeneration","author":"Stone","year":"2009","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.jaut.2016.08.005_bib74","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.pneurobio.2007.09.002","article-title":"Adenosine A2A receptors and brain injury: broad spectrum of neuroprotection, multifaceted actions and \u201cfine tuning\u201d modulation","volume":"83","author":"Chen","year":"2007","journal-title":"Prog. Neurobiol."},{"issue":"1","key":"10.1016\/j.jaut.2016.08.005_bib75","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/ene.12883","article-title":"Disease-modifying treatments for multiple sclerosis - a review of approved medications","volume":"23","author":"Torkildsen","year":"2016","journal-title":"Eur. J. Neurol."},{"issue":"1","key":"10.1016\/j.jaut.2016.08.005_bib76","first-page":"S17","article-title":"Interferon-beta mechanisms of action in multiple sclerosis","volume":"74","author":"Dhib-Jalbut","year":"2010","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jaut.2016.08.005_bib77","first-page":"S25","article-title":"The mechanism of action of glatiramer acetate treatment in multiple sclerosis","volume":"74","author":"Racke","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2016.08.005_bib78","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1586\/ecp.12.56","article-title":"Teriflunomide for oral therapy in multiple sclerosis","volume":"5","author":"Papadopoulou","year":"2012","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"10.1016\/j.jaut.2016.08.005_bib79","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s11910-013-0394-8","article-title":"Dimethyl fumarate for treatment of multiple sclerosis: mechanism of action, effectiveness, and side effects","volume":"13","author":"Linker","year":"2013","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.jaut.2016.08.005_bib80","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1056\/NEJMoa044397","article-title":"A\u00a0randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis","volume":"354","author":"Polman","year":"2006","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jaut.2016.08.005_bib81","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1056\/NEJMoa0909494","article-title":"A\u00a0placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis","volume":"362","author":"Kappos","year":"2010","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jaut.2016.08.005_bib82","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2147\/DDDT.S32687","article-title":"Alemtuzumab: evidence for its potential in relapsing-remitting multiple sclerosis","volume":"7","author":"Brown","year":"2013","journal-title":"Drug Des. Devel Ther."},{"key":"10.1016\/j.jaut.2016.08.005_bib83","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.autrev.2016.03.006","article-title":"Therapeutic strategies targeting B-cells in multiple sclerosis","volume":"15","author":"Milo","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2016.08.005_bib84","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(09)60995-8","article-title":"Schizophrenia","volume":"374","author":"van Os","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2016.08.005_bib85","doi-asserted-by":"crossref","first-page":"257184","DOI":"10.1155\/2013\/257184","article-title":"Autoantibodies and the immune hypothesis in psychotic brain diseases: challenges and perspectives","volume":"2013","author":"Pathmanandavel","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.jaut.2016.08.005_bib86","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1600-0447.1999.tb05985.x","article-title":"Schizophrenia and the disconnection hypothesis","volume":"395","author":"Friston","year":"1999","journal-title":"Acta Psychiatr. Scand. Suppl."},{"key":"10.1016\/j.jaut.2016.08.005_bib87","article-title":"Autoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: more than a gut feeling","author":"Severance","year":"2014","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jaut.2016.08.005_bib88","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/schbul\/sbp055","article-title":"Prevalence of celiac disease and gluten sensitivity in the United States clinical antipsychotic trials of intervention effectiveness study population","volume":"37","author":"Cascella","year":"2011","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.jaut.2016.08.005_bib89","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.schres.2009.08.009","article-title":"Novel immune response to gluten in individuals with schizophrenia","volume":"118","author":"Samaroo","year":"2010","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jaut.2016.08.005_bib90","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s13317-014-0064-0","article-title":"Celiac and non-celiac gluten sensitivity: a review on the association with schizophrenia and mood disorders","volume":"5","author":"Porcelli","year":"2014","journal-title":"Auto. Immun. Highlights"},{"key":"10.1016\/j.jaut.2016.08.005_bib91","doi-asserted-by":"crossref","first-page":"7038","DOI":"10.4049\/jimmunol.175.10.7038","article-title":"Gliadin fragments induce phenotypic and functional maturation of human dendritic cells","volume":"175","author":"Palova-Jelinkova","year":"2005","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2016.08.005_bib92","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.4049\/jimmunol.176.4.2512","article-title":"Gliadin stimulation of murine macrophage inflammatory gene expression and intestinal permeability are MyD88-dependent: role of the innate immune response in Celiac disease","volume":"176","author":"Thomas","year":"2006","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2016.08.005_bib93","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11126-011-9186-y","article-title":"Neurologic and psychiatric manifestations of celiac disease and gluten sensitivity","volume":"83","author":"Jackson","year":"2012","journal-title":"Psychiatr. Q."},{"key":"10.1016\/j.jaut.2016.08.005_bib94","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/brain\/awg050","article-title":"Gluten ataxia in perspective: epidemiology, genetic susceptibility and clinical characteristics","volume":"126","author":"Hadjivassiliou","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.jaut.2016.08.005_bib95","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1196\/annals.1381.034","article-title":"Gluten ataxia: passive transfer in a mouse model","volume":"1107","author":"Boscolo","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jaut.2016.08.005_bib96","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.schres.2012.06.011","article-title":"A\u00a0gluten-free diet in people with schizophrenia and anti-tissue transglutaminase or anti-gliadin antibodies","volume":"140","author":"Jackson","year":"2012","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jaut.2016.08.005_bib97","doi-asserted-by":"crossref","first-page":"e1002004","DOI":"10.1371\/journal.ppat.1002004","article-title":"Viral encephalomyelitis","volume":"7","author":"Griffin","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jaut.2016.08.005_bib98","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1086\/509330","article-title":"Beyond viruses: clinical profiles and etiologies associated with encephalitis","volume":"43","author":"Glaser","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jaut.2016.08.005_bib99","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.pneurobio.2009.12.003","article-title":"Emergence and re-emergence of viral diseases of the central nervous system","volume":"91","author":"Griffin","year":"2010","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.jaut.2016.08.005_bib100","first-page":"493","article-title":"Use of rabies virus as a transneuronal tracer of neuronal connections: implications for the understanding of rabies pathogenesis","volume":"131","author":"Ugolini","year":"2008","journal-title":"Dev. Biol. (Basel)"},{"key":"10.1016\/j.jaut.2016.08.005_bib101","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1128\/JVI.01718-08","article-title":"Herpesvirus interactions with the host cytoskeleton","volume":"83","author":"Lyman","year":"2009","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.jaut.2016.08.005_bib102","doi-asserted-by":"crossref","first-page":"5352","DOI":"10.1128\/JVI.74.11.5352-5356.2000","article-title":"Activation of divergent neuronal cell death pathways in different target cell populations during neuroadapted sindbis virus infection of mice","volume":"74","author":"Havert","year":"2000","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.jaut.2016.08.005_bib103","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2009.09.013","article-title":"Herpes simplex type I (HSV-1) infection of the nervous system: is an immune response a good thing?","volume":"220","author":"Conrady","year":"2010","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.jaut.2016.08.005_bib104","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1073\/pnas.0712390105","article-title":"Protection from fatal viral encephalomyelitis: AMPA receptor antagonists have a direct effect on the inflammatory response to infection","volume":"105","author":"Greene","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jaut.2016.08.005_bib105","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s12026-009-8143-4","article-title":"Recovery from viral encephalomyelitis: immune-mediated noncytolytic virus clearance from neurons","volume":"47","author":"Griffin","year":"2010","journal-title":"Immunol. Res."},{"key":"10.1016\/j.jaut.2016.08.005_bib106","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1128\/JVI.79.6.3438-3447.2005","article-title":"Characterization of an in\u00a0vitro model of alphavirus infection of immature and mature neurons","volume":"79","author":"Vernon","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.jaut.2016.08.005_bib107","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1128\/JVI.02381-08","article-title":"Noncytolytic clearance of sindbis virus infection from neurons by gamma interferon is dependent on Jak\/STAT signaling","volume":"83","author":"Burdeinick-Kerr","year":"2009","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.jaut.2016.08.005_bib108","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1128\/jvi.69.3.1990-1993.1995","article-title":"Roles of immunoglobulin valency and the heavy-chain constant domain in antibody-mediated downregulation of Sindbis virus replication in persistently infected neurons","volume":"69","author":"Ubol","year":"1995","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.jaut.2016.08.005_bib109","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1126\/science.1658936","article-title":"Antibody-mediated clearance of alphavirus infection from neurons","volume":"254","author":"Levine","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.jaut.2016.08.005_bib110","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.4049\/jimmunol.149.12.4016","article-title":"Long term intraparenchymal Ig secretion after acute viral encephalitis in mice","volume":"149","author":"Tyor","year":"1992","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2016.08.005_bib111","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s12026-015-8718-1","article-title":"Neural circuitry and immunity","volume":"63","author":"Pavlov","year":"2015","journal-title":"Immunol. Res."},{"key":"10.1016\/j.jaut.2016.08.005_bib112","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/nn.3144","article-title":"Neurogenic inflammation and the peripheral nervous system in host defense and immunopathology","volume":"15","author":"Chiu","year":"2012","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jaut.2016.08.005_bib113","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.it.2015.08.007","article-title":"The regulation of immunological processes by peripheral neurons in homeostasis and disease","volume":"36","author":"Ordovas-Montanes","year":"2015","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jaut.2016.08.005_bib114","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/35013070","article-title":"Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin","volume":"405","author":"Borovikova","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2016.08.005_bib115","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nrrheum.2012.181","article-title":"Role of peripheral nerve fibres in acute and chronic inflammation in arthritis","volume":"9","author":"Pongratz","year":"2013","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jaut.2016.08.005_bib116","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1006\/brbi.1999.0564","article-title":"Dual role for noradrenergic innervation of lymphoid tissue and arthritic joints in adjuvant-induced arthritis","volume":"13","author":"Lorton","year":"1999","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jaut.2016.08.005_bib117","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1002\/art.20987","article-title":"An opposing time-dependent immune-modulating effect of the sympathetic nervous system conferred by altering the cytokine profile in the local lymph nodes and spleen of mice with type II collagen-induced arthritis","volume":"52","author":"Harle","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2016.08.005_bib118","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1136\/ard.2011.153056","article-title":"The sympathetic nervous system stimulates anti-inflammatory B cells in collagen-type II-induced arthritis","volume":"71","author":"Pongratz","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2016.08.005_bib119","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.4049\/jimmunol.166.3.1635","article-title":"Adjuvant arthritis induces down-regulation of G protein-coupled receptor kinases in the immune system","volume":"166","author":"Lombardi","year":"2001","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2016.08.005_bib120","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1136\/gut.2007.125401","article-title":"Anti-inflammatory role of sympathetic nerves in chronic intestinal inflammation","volume":"57","author":"Straub","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2016.08.005_bib121","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/1523-1747.ep13071340","article-title":"Quantification of cutaneous sensory nerves and their substance P content in psoriasis","volume":"92","author":"Naukkarinen","year":"1989","journal-title":"J.\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaut.2016.08.005_bib122","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1096\/fj.99-1082com","article-title":"The loss of sympathetic nerve fibers in the synovial tissue of patients with rheumatoid arthritis is accompanied by increased norepinephrine release from synovial macrophages","volume":"14","author":"Miller","year":"2000","journal-title":"FASEB J."},{"key":"10.1016\/j.jaut.2016.08.005_bib123","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3389\/fphys.2012.00284","article-title":"Sympathetic regulation of vascular function in health and disease","volume":"3","author":"Bruno","year":"2012","journal-title":"Front. Physiol."},{"key":"10.1016\/j.jaut.2016.08.005_bib124","article-title":"Skin microbiota-associated inflammation precedes autoantibody induced tissue damage in experimental epidermolysis bullosa acquisita","author":"Ellebrecht","year":"2015","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jaut.2016.08.005_bib125","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jaut.2014.03.005","article-title":"Long term effect of gut microbiota transfer on diabetes development","volume":"53","author":"Peng","year":"2014","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jaut.2016.08.005_bib126","article-title":"Risk factors in autism: thinking outside the brain","author":"Matelski","year":"2015","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jaut.2016.08.005_bib127","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s40474-016-0077-7","article-title":"The brain-gut-microbiome axis: what role does it play in autism spectrum disorder?","volume":"3","author":"Luna","year":"2016","journal-title":"Curr. Dev. Disord. Rep."},{"key":"10.1016\/j.jaut.2016.08.005_bib128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2014.05.001","article-title":"Myasthenia Gravis: paradox versus paradigm in autoimmunity","volume":"52","author":"Berrih-Aknin","year":"2014","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jaut.2016.08.005_bib129","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jaut.2013.12.004","article-title":"A\u00a0comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis","volume":"52","author":"Zisimopoulou","year":"2014","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jaut.2016.08.005_bib130","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jaut.2014.01.003","article-title":"Diagnostic and clinical classification of autoimmune myasthenia gravis","volume":"48\u201349","author":"Berrih-Aknin","year":"2014","journal-title":"J.\u00a0Autoimmun."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841116301354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841116301354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:15:06Z","timestamp":1760256906000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841116301354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":130,"alternative-id":["S0896841116301354"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2016.08.005","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current trends in autoimmunity and the nervous system","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2016.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}